BioMed Research International

Review Article

CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors

Table 1

Expression of chemokine receptor in various solid tumors.
CancerReceptor expressed References
BreastCXCR1, CXCR2, CXCR4, and CXCR7[7], [19], [20], [21], [22]
OvarianCXCR4[7], [19], [23], [24], [25], [26]
ProstateCXCR1, CXCR2, and CXCR4[7], [19], [27], [28]
Lung (NSCLC)CXCR2, CXCR4, and CCR7[7], [19], [29], [30], [31], [32]
EsophagealCXCR4[7], [19]
StomachCXCR4, CXCR6, and CCR7[7], [19], [33], [34]
ColorectalCXCR2, CXCR4, CCR6, and CCR7[7], [19], [35], [36]
PancreasCXCR2, CXCR3, CXCR4, and CCR7[7], [19]
BladderCXCR4, CXCR7[7], [19], [37]
KidneyCXCR3, CXCR4, CXCR6, CXCR7, CCR2, CCR5, and CCR6[7], [19], [38]
MelanomaCXCR4, CXCR10, CCR7, and CCR9[7], [19], [39], [40]
Head and neckCXCR1, CXCR2, CXCR4, CCR7, and CXCR5[7], [19], [41]
Brain CXCR2, CXCR3, CXCR4, and CCRL2[7], [19], [42], [43], [44], [45]
OsteosarcomaCXCR4, CCR5[7], [19]
NeuroblastomaCXCR4, CXCR7[7], [19]